Pancreatic Cancer Research

ResearcherChinese PLA General HospitalActive in the last 2 years

Min Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5498-3434; OpenAlex author ID A5058802996. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Asia's accelerating burden of early-onset pancreatic cancer: a 32-year global comparative analysis using GBD 2021. Co-author DOI 10.1097/js9.0000000000003864↗
  2. Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer. Co-author DOI 10.1080/07853890.2023.2242247↗
  3. Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.18632/oncotarget.13950↗
  4. Literature-based knowledgebase of pancreatic cancer gene to prioritize the key genes and pathways. Last author DOI 10.1016/j.jgg.2016.04.006↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunyi Hao · 2 shared papers, 2017–2023 · strength 0.26
  2. Dao-Ning Liu · 2 shared papers, 2017–2023 · strength 0.26
  3. Yao He · 1 shared paper, 2026 · strength 0.22
  4. Xiaoxin Ye · 1 shared paper, 2026 · strength 0.22
  5. Weijia Wang · 1 shared paper, 2023 · strength 0.18
  6. Jianhui Wu · 1 shared paper, 2023 · strength 0.18
  7. Yining Liu · 1 shared paper, 2016 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.